AU Patent

AU2019208331B2 — Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors

Assigned to Cytokinetics Inc · Expires 2024-05-02 · 2y expired

What this patent protects

Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R

USPTO Abstract

Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R

Drugs covered by this patent

Patent Metadata

Patent number: AU2019208331B2
Jurisdiction: AU
Classification: —
Expires: 2024-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Cytokinetics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.